|
⚲
|
| Keyboard |
| Lee Sam
✚
|
|
|---|---|
| CIK # | 0001602074 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001602074] | |
| 4 | [0001602074] | |
| 5 | [0001602074] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lee Sam | |
| Biozone Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biozone Pharmaceuticals Inc COCP
Stock Options (Right to Buy) · derivative
|
2026-01-09 | Grant | 49,229 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2024-10-09 | Grant | 40,000 | ||
|
Biozone Pharmaceuticals Inc COCP
Stock Options (Right to Buy) · derivative
|
2023-07-18 | Grant | 30,000 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
Stock Options (Right to Buy) · derivative
|
2022-07-25 | Grant | 300,000 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
Stock Options (Right to Buy) · derivative
|
2021-07-16 | Grant | 250,000 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
Stock Options (Right to Buy) · derivative
|
2020-11-24 | Grant | 50,000 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
Stock Options (Right to Buy) · derivative
|
2020-06-22 | Grant | 100,000 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
Stock Options (Right to Buy) · derivative
|
2018-09-21 | Grant | 100,000 | $0.00 | |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2016-12-23 | Sell | 2,200,000 | $0.44 | 968,000 |
|
Biozone Pharmaceuticals Inc COCP
Common Stock
|
2015-03-03 | Option exercise | 15,287,847 | ||
|
Biozone Pharmaceuticals Inc COCP
Series B Preferred Stock · derivative
|
2015-03-03 | Option exercise | 74,545 |